Literature DB >> 31993967

Burden of Gastroduodenal Diseases from the Global Perspective.

Vladimir Milivojevic1,2, Tomica Milosavljevic3.   

Abstract

PURPOSE OF REVIEW: We reviewed the recent medical literature to show global burden of gastroduodenal disease, potential strategies, and further perspectives. RECENT
FINDINGS: Gastrointestinal and liver diseases are growing health problems, and cause more than 8 million deaths per year worldwide; encompass a range of long-term health conditions, such as digestive cancers, gastroesophageal reflux disease, Helicobacter pylori infection, peptic ulcer disease, liver diseases, inflammatory bowel disease, coeliac disease, and functional gastrointestinal disorders. Scientific knowledge demonstrates that the noncommunicable disease burden can be greatly reduced if cost-effective preventive and curative actions, along with interventions for prevention and control of noncommunicable diseases already available, are implemented in an effective and balanced manner. Future research will have to elaborate on simple methods for preselection of patients at high risk to allow their implementation in strategies and respect all demand of cost-effectiveness. Understanding trends in GI illnesses could be helpful to meet the needs of patients and decrease the disease burden.

Entities:  

Keywords:  Gastric cancer; Gastroesophageal reflux disease; Global burden; Helicobacter pylori; Peptic ulcer

Year:  2020        PMID: 31993967     DOI: 10.1007/s11938-020-00277-z

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  32 in total

Review 1.  ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.

Authors:  Neena S Abraham; Mark A Hlatky; Elliott M Antman; Deepak L Bhatt; David J Bjorkman; Craig B Clark; Curt D Furberg; David A Johnson; Charles J Kahi; Loren Laine; Kenneth W Mahaffey; Eamonn M Quigley; James Scheiman; Laurence S Sperling; Gordon F Tomaselli
Journal:  Am J Gastroenterol       Date:  2010-12       Impact factor: 10.864

Review 2.  Time trends of gastroesophageal reflux disease: a systematic review.

Authors:  Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2006-12-04       Impact factor: 11.382

3.  Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.

Authors:  P Malfertheiner; F Megraud; C A O'Morain; J P Gisbert; E J Kuipers; A T Axon; F Bazzoli; A Gasbarrini; J Atherton; D Y Graham; R Hunt; P Moayyedi; T Rokkas; M Rugge; M Selgrad; S Suerbaum; K Sugano; E M El-Omar
Journal:  Gut       Date:  2016-10-05       Impact factor: 23.059

4.  Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection.

Authors:  M Zamani; F Ebrahimtabar; V Zamani; W H Miller; R Alizadeh-Navaei; J Shokri-Shirvani; M H Derakhshan
Journal:  Aliment Pharmacol Ther       Date:  2018-02-12       Impact factor: 8.171

Review 5.  Epidemiology of Helicobacter pylori infection and gastric cancer in Asia.

Authors:  Kwong Ming Fock; Tiing Leong Ang
Journal:  J Gastroenterol Hepatol       Date:  2010-03       Impact factor: 4.029

6.  The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010.

Authors:  C Musumba; A Jorgensen; L Sutton; D Van Eker; J Moorcroft; M Hopkins; D M Pritchard; M Pirmohamed
Journal:  Aliment Pharmacol Ther       Date:  2012-05-03       Impact factor: 8.171

Review 7.  Smoking and gastric cancer: systematic review and meta-analysis of cohort studies.

Authors:  Ricardo Ladeiras-Lopes; Alexandre Kirchhofer Pereira; Amanda Nogueira; Tiago Pinheiro-Torres; Isabel Pinto; Ricardo Santos-Pereira; Nuno Lunet
Journal:  Cancer Causes Control       Date:  2008-02-22       Impact factor: 2.506

Review 8.  Systematic review: the global incidence and prevalence of peptic ulcer disease.

Authors:  J J Y Sung; E J Kuipers; H B El-Serag
Journal:  Aliment Pharmacol Ther       Date:  2009-05-01       Impact factor: 8.171

Review 9.  Epidemiological trends in stomach-related diseases.

Authors:  Tomica Milosavljević; Mirjana Kostić-Milosavljević; Miodrag Krstić; Aleksandra Sokić-Milutinović
Journal:  Dig Dis       Date:  2014-04-10       Impact factor: 2.404

Review 10.  Kyoto global consensus report on Helicobacter pylori gastritis.

Authors:  Kentaro Sugano; Jan Tack; Ernst J Kuipers; David Y Graham; Emad M El-Omar; Soichiro Miura; Ken Haruma; Masahiro Asaka; Naomi Uemura; Peter Malfertheiner
Journal:  Gut       Date:  2015-07-17       Impact factor: 23.059

View more
  3 in total

1.  Molecular epidemiology and surveillance of circulating rotavirus among children with gastroenteritis in Bangladesh during 2014-2019.

Authors:  Shuvra Kanti Dey; Nadim Sharif; Omar Sadi Sarkar; Mithun Kumar Sarkar; Ali Azam Talukder; Tung Phan; Hiroshi Ushijima
Journal:  PLoS One       Date:  2020-11-30       Impact factor: 3.240

Review 2.  The Role of CCN1 in Esophageal Adenocarcinoma: What We Have Learned From the Lab.

Authors:  Zhiheng Chang; Tong Dang; Xianmei Meng; Jianyuan Chai
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 3.302

3.  Red Propolis and Its Dyslipidemic Regulator Formononetin: Evaluation of Antioxidant Activity and Gastroprotective Effects in Rat Model of Gastric Ulcer.

Authors:  Marcio A A de Mendonça; Ana R S Ribeiro; Adriana K de Lima; Gislaine B Bezerra; Malone S Pinheiro; Ricardo L C de Albuquerque-Júnior; Margarete Z Gomes; Francine F Padilha; Sara M Thomazzi; Ettore Novellino; Antonello Santini; Patricia Severino; Eliana B Souto; Juliana C Cardoso
Journal:  Nutrients       Date:  2020-09-26       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.